Amal Rayan

10PUBLICATIONS
9CO-AUTHORS
Haematological tumoursPredictive and prognostic markersTumour immunologyMedical infection agents (incl. prions)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 12, 2026
Could the Immune Modulation of Invariant Natural Killer T Cell and the Expression of CD244 and CD196 on Natural Killer Cell Subtypes Impact the Treatment Outcomes of Acute Myeloid Leukemia Patients?

|May 12, 2023
Applying a neoscore in locally advanced rectal cancer is beneficial in predicting local recurrences after surgery.

Amal Rayan, Ahmed Soliman

|Mar 29, 2023
Peripheral Mononuclear Cells Surface Markers Evaluation in Different Stages of Hepatocellular Carcinoma; in a Trial for Early and Accurate Diagnosis in Patients with Post-Hepatitis Liver Cirrhosis and Unremarkable Raised AFP.

Heba Ahmed Osman, Hanaa Nafady-Hego, Khalid Ali Nasif

|Jan 20, 2022
Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer.

Asmaa M Zahran, Amal Rayan, Zeinab Albadry M Zahran

|Aug 11, 2021
Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Can Boost Immune Disruption.

Asmaa M Zahran, Omnia El-Badawy, Lamiaa M Kamel

|Feb 22, 2021
Circulating microparticles and activated platelets as novel prognostic biomarkers in COVID-19; relation to cancer.

Asmaa M Zahran, Omnia El-Badawy, Wageeh A Ali

Pageof 2

Frequent Collaborators

2 joint publications

Mona H Abdel-Rahim

1 joint publications

Ahmad F Thabet

1 joint publications

Helal F Hetta

1 joint publications

Asmaa M Zahran